MetaCap

Aurinia Pharmaceuticals Statistics

NASDAQ: AUPHHealth CareBiotechnology: Pharmaceutical PreparationsUSD

14.70-0.19 (-1.28%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Aurinia Pharmaceuticals by the numbers

Aurinia Pharmaceuticals has a market capitalization of $1.97 billion based on 134.00M shares outstanding. Its trailing P/E ratio is 6.4, and its forward P/E is 12.7. The stock trades 10.3% below its 50-day average and 6.6% below its 200-day average.

Average daily trading volume is 858.74K shares, or about $12.6 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

AUPH valuation vs. peer median

AUPH compared with the median of 8 peer companies
MetricAUPHPeer medianDifference
Market cap$1.97B$1.86B+6%
Avg. volume858.74K1.66M-48%

Peer median across 8 companies: HRMY, TRVI, PVLA, BHVN, IMNM, VERA, SEPN, MRVI.

Valuation

Price / sales (latest FY)
6.96

Price and trading

Previous close
14.89
Open
14.72
Day range
14.63 – 14.97
52-week range
13.52 – 19.25
52-week change
-6.25%
Beta
—
Volume
1.34M

Dividends and events

Annual dividend
None
Next earnings date
Oct 30, 2026

Additional statistics

Market Cap
1.97B
Pe
6.45
Forward Pe
12.67
Eps
2.28
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
19.25
Week52 Low
13.52
Avg Volume
858.74K
Shares Outstanding
134.00M
Ma50
16.38
Ma200
15.74
Earnings Date
Oct 30, 2026
Pct From52w High
-23.64%
Pct From52w Low
8.73%

Related